PR Newswire press releases
Full-text press releases distributed by PR Newswire, newest first. Times are US Eastern.
Source: PR Newswire
DIRECTV Adds NHL's New Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues Regional Channels
DIRECTV today announced a new multi-year distribution agreement with the National Hockey League for Hurricanes Hockey Network, Blue Jackets Hockey Network, Wild+, and Blue Note+ pregame, postgame, and in-game live sports services.
Axon Announces Body 5: Next-Generation Camera Built for the AI Era
Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more powerful intelligence, connectivity and real-time support directly to officers in the field.
BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit
BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit
In HelloNation, Behavioral Health Experts Cody Luke and David Spencer Explain What to Expect During Your First Therapy Session
What should you expect during your first therapy session? HelloNation published an article that answers this question, featuring insights from Behavioral Health Experts Cody Luke and David Spencer of Luke and Spencer Behavioral Health, PLLC in Idaho Falls, Idaho.
In HelloNation, Custom Fabrication Expert Mark Coyle Explains a Common Mistake in Custom Aluminum Design
What early design choice causes many custom aluminum projects to become heavier, costlier, or harder to manufacture? That question is addressed in a HelloNation article featuring insights from Custom Fabrication Expert Mark Coyle of American Custom Metals, Inc. in Rochester, New York, that outlines how misunderstanding aluminum behavior leads designers to rely on thick walls instead of stronger geometry.
ASTS Deadline in 20 Days: AST SpaceMobile, Inc Class Action Lawsuit: Investors Face November 13, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP
Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against AST SpaceMobile, Inc. (AST) (NASDAQ: ASTS) on behalf of those who purchased or acquired AST securities between March 4, 2025 and July 15, 2026, inclusive. The lawsuit is filed in the United States District Court for the Western District of Texas and is captioned Hunter v. AST SpaceMobile, Inc., No. 7:26-cv-00378 (W.D. Tex.). Investors have until November 13, 2026, to file for lead plaintiff status.
World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang
This is a report by China Daily:
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% as a first-line maintenance treatment for extensive stage small cell lung cancer (ES-SCLC) (hazard ratio [HR]: 0.42; 95% confidence interval [CI]: 0.32, 0.54; P < 0.001) at a median follow-up of approximately 16 months. The DeLLphi-305 study found that IMDELLTRA in combination with durvalumab extended median overall survival (OS) by more than eight months to 21.1 months compared with 12.7 months with durvalumab alone for patients with ES-SCLC who had not progressed following initial treatment with durvalumab, platinum-based chemotherapy and etoposide. The clinical implications of these findings are substantial and suggest that earlier use of IMDELLTRA could markedly alter the trajectory of a disease previously considered extremely difficult to control. The data are being presented during a Presidential Symposium (abstract LBA3) at the European Society for Medical Oncology (ESMO) Congress 2026 and simultaneously published in The New England Journal of Medicine.1
Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
Non-Invasive Flow Measurement Technology: Optimizing Complex Process Infrastructure via the DT-TDS 200 Series Ultrasonic Flow Meters from Drive Test GmbH
Accurate volumetric flow determination within industrial piping networks—across power generation, chemical process engineering, HVAC systems, and water management—remains a cornerstone of thermal efficiency, regulatory compliance, and dynamic process control. As a specialized developer and manufacturer of advanced measuring systems, Drive Test GmbH addresses these critical process requirements with its high-performance diagnostic instrumentation. Traditional inline flowmeters, such as magnetic inductive, turbine, or orifice plate devices, present inherent mechanical and operational constraints. Retrofitting or maintaining inline sensors typically necessitates pipe sectioning, system depressurization, and costly production interruptions. Furthermore, fluid-wetted components introduce potential leak paths, parasitic pressure drops, and susceptibility to chemical corrosion or mechanical erosion. To eliminate these operational vulnerabilities, process engineers increasingly implement clamp-on ultrasonic flowmeters. The DT-TDS 200 series from Drive Test GmbH offers a portable, high-precision, non-invasive diagnostic solution designed to capture fluid dynamics externally without compromising line integrity or interrupting continuous plant operations.
In HelloNation, Insurance Expert Devery Prince Breaks Down Affordable Insurance in Alaska
What does affordable insurance actually cover for homeowners in Alaska? HelloNation has published a HelloNation article that answers this question for residents across the state.
Swanson Vitamins Launches Swanson Vitamins Nexus Pro to Champion Registered Dietitians and Licensed Nutritionists at Every Stage of Their Careers
Swanson Vitamins today launched Swanson Vitamins Nexus Pro, a network for health and nutrition professionals. The new initiative champions registered dietitians and licensed nutritionists through every stage of their careers, from students to providers with decades of experience. Created by nutrition professionals for nutrition professionals, Swanson Vitamins Nexus Pro offers educational resources, incentives and investments to support practitioners who share Swanson's commitment to uncompromising integrity.
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Darden Restaurants, Inc. for Alleged Failure to Reimburse Employees' Business Expenses
The San Diego employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action complaint alleging that Darden Restaurants, Inc. violated the California Labor Code. The Darden Restaurants, Inc. class action lawsuit, Case No. 26CU049159C, is currently pending in the San Diego County Superior Court of the State of California. A copy of the Complaint can be read here.
The Secret to Getting on a New York Wine List? Four Master Sommeliers Come Face to Face with Leading Italian Producers
A wine can have a US importer, great reviews and a loyal following back home, and still never reach a New York wine list. What do the people who create those lists actually want? On Monday 26 October, wine2wine Vinitaly Business Forum – New York Edition will put the question directly to four Master Sommeliers (MS), live on stage, in front of Italian producers and the American trade.
The Ultimate Send-off to Summer: CSTS Debuts Global Entertainment IP PremierX at New York's Pier 17, Ushering in a New Era of Live Entertainment
CSTS Enterprises ('CSTS'), a New York-based sports, entertainment, integrated media and travel technology group, today announced the official launch of PremierXTM, its flagship live entertainment brand, with a landmark Halloween Weekend event "AFTER DARK" at The Rooftop at Pier 17 in New York on October 30, 2026.
TYGO Investors Have Opportunity to Lead Tigo Energy, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tigo Energy, Inc. (NASDAQ: TYGO) between February 24, 2026 and August 4, 2026, both dates inclusive (the "Class Period"), of the important November 23, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem
Expectations for travel are evolving: vehicles are no longer simply a means of reaching a destination, but travel companions that bring people closer to nature, serving as a "mobile third space."
BULL Investors Have Opportunity to Lead Webull Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Webull Corporation (NASDAQ: BULL) between April 26, 2025 and October 6, 2026, both dates inclusive (the "Class Period"), of the important December 7, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Ensign Group, Inc. (NASDAQ: ENSG) between February 10, 2022 and June 18, 2026, both dates inclusive (the "Class Period"), of the important December 7, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026
Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi Future Health Summit 2026, held from 20 to 22 October at ADNEC Centre Abu Dhabi. The summit marked a milestone in Likang's international outreach, showcasing its scientific platform and clinical development programs.
Taiwan Brings Herbal Heritage and Modern Innovation to SupplySide Global 2026
With a healthcare system that embraces both modern medicine and Traditional Chinese medicine (TCM), Taiwan brings together herbal knowledge passed down over millennia, scientific evidence and modern pharmaceutical and biotechnology capabilities. Supported by the Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare, and organized by the Taiwan Institute of Economic Research, the Taiwan Traditional Chinese Medicine Pavilion will showcase four companies from the TCM and biotechnology sectors at SupplySide Global 2026 (Booth 7228), held October 28–30 in Las Vegas, translating this foundation into natural health ingredients, innovative wellness products and manufacturing partnerships for the global health and nutrition industry.
Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026
Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi Future Health Summit 2026, held from 20 to 22 October at ADNEC Centre Abu Dhabi. The summit marked a milestone in Likang's international outreach, showcasing its scientific platform and clinical development programs.
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026
Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation of clinical data for BAT8008, a TROP2-targeted antibody-drug conjugate (ADC), in combination with BAT1308, an anti-PD-1 monoclonal antibody, at the 2026 European Society for Medical Oncology (ESMO) Congress. Professor Shaodong Hong of Sun Yat-sen University Cancer Center delivered a rapid oral presentation highlighting results from the combination regimen in patients with non-small cell lung cancer (NSCLC). Further details are available on Bio-Thera's official website.
Best AI Tools for Marketing Content (2026): CapCut Recognized for Faster AI-Powered Video and Image Creation by Better Business Advice
Better Business Advice has recognized CapCut in its 2026 coverage of the best AI tools for marketing content, highlighting its collection of AI-powered features for creating and editing videos, images, audio, and other campaign assets. The recognition reflects growing interest in tools that help transform creative concepts into usable marketing materials while reducing the manual work involved in production.
Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society for Medical Oncology (ESMO) Congress held in Madrid, updated results from the Phase II MK-2870-002/SKB264-II-06 study of sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870)(佳泰莱®) plus MSD's[1] anti-programmed cell death protein 1 (PD-1) monoclonal antibody pembrolizumab (KEYTRUDA®[2]) in locally advanced or metastatic urothelial carcinoma (la/mUC) were presented as a rapid oral report by Professor Xiaojie Bian from Fudan University Shanghai Cancer Center (4739RO; Rapid oral | Genitourinary Tumours, Renal and Urothelial).
2026 China Marine Economy Expo Kicks Off: Embarking Together on a Journey Toward Digital and Smart Ocean
On October 22, Shenzhen World Exhibition & Convention Center was illuminated in a deep ocean blue as the 2026 China Marine Economy Expo—themed "Digital and Smart Ocean: Co-creating a Sustainable Future"—officially opened. Spanning an exhibition area of 50,000 square meters, the expo hosts over 350 enterprises and is expected to attract 25,000 professional visits. It focuses on core marine sectors and cutting-edge fields, featuring eight exhibition zones including integrated deep-sea and far-sea energy development and application, green shipping and low-carbon logistics, marine electronic information, marine ecology and sustainable development, offshore applications of the low-altitude economy, full-space marine monitoring and disaster early warning, marine biomedicine, and modern marine services and coastal cultural tourism, as well as three specialized exhibition zones dedicated to international participation, industrial clusters, and accelerated technological innovation, which together present the complete ecosystem of marine industries across their entire value chain.
Best Magnetic Stand Cases for iPhone 18 Pro & iPhone 18 Pro Max in 2026: TORRAS Recognized as a Top Choice by Expert Consumers
Expert Consumers has recognized the TORRAS Magnetic Stand Case as a top choice for iPhone 18 Pro and iPhone 18 Pro Max users seeking built-in stand functionality, magnetic accessory support, and everyday convenience. The recognition highlights TORRAS's Q-series and O-series lineup, including Q3 Spin, O3 Fitness, Q3 Silicone, Q3 Wind, Q3 VegSkin, and Q3 Air Essential.
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given for six months before and after surgery, with radical prostatectomy alone in patients with high-risk localized or locally advanced prostate cancer. The apalutamide plus ADT regimen reduced the risk of disease recurrence or death by 62 percent compared with surgery alone. The regimen also showed a numerical improvement in metastasis-free survival (MFS), with a 51 percent lower risk of metastasis or death. Patients receiving apalutamide plus ADT also went longer before needing subsequent therapy.1
ASTRI Showcases Pioneering Technologies at InnoCarnival 2026
The Hong Kong Applied Science and Technology Research Institute (ASTRI) is proud to present a range of cutting-edge technologies and practical solutions at this year's InnoCarnival, spanning communications technology, smart cities, IoT sensing, and renewable energy and energy storage. ASTRI's innovations address urban development needs and everyday applications, driving diversity in the innovation and technology (I&T) sector.
HKAGE Showcases Gifted Students' Learning Journeys at InnoCarnival 2026
The Hong Kong Academy for Gifted Education (HKAGE) has been invited to participate in InnoCarnival 2026, organised by the Innovation and Technology Commission. Under the theme "Technology for Good, Innovation for All", HKAGE will showcase the learning journeys of gifted students who have completed programmes on AI robotic arms, underwater archaeology, etc., demonstrating how technology can be harnessed to address societal needs.
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026
Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its investigational folate receptor alpha (FRα) antibody-drug conjugate (ADC) sofetabart mipitecan (Sofe-M) plus bevacizumab achieved a confirmed objective response rate (cORR) of 79% and a disease control rate (DCR) of 100% in patients with platinum-sensitive ovarian cancer (PSOC). A cORR of 79% or higher was seen in both poly (ADP-ribose) polymerase inhibitor (PARPi)-treated and PARPi-naïve patients. These data will be shared in an oral presentation at the European Society for Medical Oncology (ESMO) Annual Congress in Madrid, Spain.
DigitalXForce Scores Triple Win: IDC MarketScape Leader Recognition, Institutional Investment from Arsenal Equity Group and 514% Growth
DigitalXForce today announced the launch of the industry's first Enterprise TRiSCM™ (Trust, Risk, and Security Management) platform designed for the AI and Quantum era, introducing a new operating model for organizations to manage Trust, Risk, Security and Compliance through continuous assurance, operational intelligence and autonomous risk operation.
The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company ("Chemours" or the "Company") (NYSE: CC), if they purchased or otherwise acquired the Company's securities between February 20, 2026 and August 4, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
Gildan Activewear Inc. Securities Fraud Class Action Result of Alleged Channel Stuffing and 18.7% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 14, 2026 to file lead plaintiff applications in a securities class action lawsuit against Gildan Activewear Inc. ("Gildan" or the "Company") (NYSE: GIL), if they purchased or otherwise acquired the Company's publicly traded securities between February 19, 2025 and June 15, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of New York.
The Ensign Group, Inc. Notice of December 7, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in The Ensign Group, Inc. (NasdaqGS: ENSG) of a class action securities lawsuit.
Millrose Properties, Inc. Securities Fraud Class Action Result of Undisclosed Rental Home Business and 8.5% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 8, 2026 to file lead plaintiff applications in a securities class action lawsuit against Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP), if they purchased or otherwise acquired the Company's securities between February 7, 2025 and October 2, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of Florida.
Honeywell Aerospace, Inc. Notice of November 23, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Honeywell Aerospace, Inc. ("Honeywell Aerospace" or the "Company") (NasdaqGS: HONA) of a class action securities lawsuit.
Duolingo, Inc. Notice of December 7, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Duolingo, Inc. (NasdaqGS: DUOL) of a class action securities lawsuit.
York Space Systems, Inc. Notice of October 30, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in York Space Systems, Inc. ("York Space Systems" or the "Company") (NYSE: YSS) of a class action securities lawsuit.
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased or otherwise acquired the Company's securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NasdaqGM: BBNX) of a class action securities lawsuit.
Think Together Celebrates 20 Years of ASES During Lights On Afterschool at 450 Schools Across California
Think Together, a division of Think Education and California's leading nonprofit provider of afterschool, expanded learning and school improvement programs, celebrated 20 years of California's After School Education and Safety (ASES) grant through nearly 450 onsite school celebrations across the state. Under this year's theme, "Partnering for Better Futures," the events highlighted the role of schools, districts, educators, families and community partners in creating meaningful opportunities for students beyond the traditional school day.
19th EU-China Business Meeting Concludes! Third-Generation Triple-Helix Biomimetic Collagen Medical Devices Make Their Global Debut, Highlights from the Event
At the 19th EU-China Business Meeting, co-hosted by the China Chamber of International Commerce (CCOIC) and the European Union Chamber of Commerce in China (EUCCC) in Chengdu, LivingPHOENIX Regenerative Technology Development (Chengdu) Co., Ltd. (hereinafter referred to as "LivingPHOENIX"), a tenant enterprise of Tianfu International Bio City, achieved a significant milestone. Dr. Qin Xingjiong, the company's founder, led his industrialization team to attend the event and witnessed the Global Launch Preview Ceremony of the company's core product: POGMENT® Triple-Helix Biomimetic Collagen-Based Extracellular Matrix (ECM) Medical Devices. This launch not only marks China's technological leap from "catching up" to "leading" in the field of high-end regenerative medicine materials but also demonstrates the strength of intelligent manufacturing in China to the international market.
Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use of Lunit SCOPE IO, Lunit's AI-powered pathology platform, for tumor microenvironment analysis in support of Summit's immuno-oncology development programs with ivonescimab.
National Vehicle Study Reveals How Long It Takes to Sell an RV
How long does it really take to sell an RV? New research from National Vehicle, a nationwide private-party RV advertising company, offers fresh insight into that question. After analyzing 10,991 RV listings and 5,174 customer-confirmed sales over a two-year period, the company found a median selling timeline of 69 days among RVs confirmed sold.
DENARIUS METALS FILES TORAL PROJECT TECHNICAL REPORT ON SEDAR+
Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or "the Company") announced today the filing of a National Instrument 43-101 – Standards of Disclosure for Mineral Projects compliant technical report in support of the Mineral Resource estimate for its 100%-owned Toral Project. The technical report, entitled "Technical Report on the Toral Zn-Pb-Ag Project, Leon Province, Castilla y Leon, Spain" with an effective date of July 24, 2026, was prepared by Resource Development Associates and supports the disclosures made by the Company in its news release dated September 9, 2026. The technical report can be found on the Company's website at www.denariusmetals.com and by reviewing its profile on SEDAR+ at www.sedarplus.ca.
NEXT PROPERTIES ANNOUNCES RESULTS OF EXCHANGE OFFERS FOR ANY & ALL OF ITS OUTSTANDING 6.950% SENIOR NOTES DUE 2044 AND 6.390% SENIOR NOTES DUE 2050 FOR ADDITIONAL 7.731% SENIOR SUSTAINABILITY-LINKED NOTES DUE 2056
NEXT Properties (Trust 2401), a trust formed under the laws of the United Mexican States (the "Trust" or "NEXT Properties"), today announced the expiration date results of its offers to exchange (collectively, the "Exchange Offers") any and all of its outstanding 6.950% Senior Notes due 2044 (the "NEXT Properties 2044 Notes") and 6.390% Senior Notes due 2050 (the "NEXT Properties 2050 Notes") for additional 7.731% Senior Sustainability-Linked Notes due 2056 (the "New 2056 Notes" or the "New Notes"), in each case upon the terms and subject to the conditions set forth in the Exchange Offer Memorandum, dated October 19, 2026 (the "Exchange Offer Memorandum"), and the related eligibility certification. The NEXT Properties 2044 Notes and the NEXT Properties 2050 Notes are herein referred to collectively as the "Old Notes." Capitalized terms used but not defined herein have the meanings assigned to them in the Exchange Offer Memorandum.
LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do
LEAP Group today announced the relaunch of HumanView, its growth intelligence service. The new version has been rebuilt from the ground up and now has a dedicated home at leapgroupnetwork.com/humanview.
Source: PR Newswire
Content provided by PR Newswire. Redistribution, resale or sublicensing is not permitted.